Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average rating of “Buy” by the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on […]
Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 7.1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a report published on Wednesday. The firm issued a buy rating on the stock. Separately, Truist Financial upped their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in a research report on Wednesday, November […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,650,000 shares, a decrease of 16.7% from the November 30th total of 3,180,000 shares. Approximately 2.4% of the shares of the company are short sold. Based […]
StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NYSE:AMRX – Free Report) in a research note published on Wednesday. The firm issued a buy rating on the stock. Other research analysts have also issued reports about the stock. Barclays boosted their price target on shares of Amneal Pharmaceuticals from $4.00 to $5.00 and gave the […]